Aanastra Inc to Present Multiple Posters on RNA Therapeutics at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 03, 2024 06:30 ET
|
Aanastra Inc
Aanastra to present its RNA peptide therapeutics technology at AACR conference
Global Factor IX Drug Pipeline Landscape Report 2024: Therapeutic Assessment by Stage, Route of Administration, and Molecule Type
February 29, 2024 10:52 ET
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Factor IX - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Hemophilia Market Size, Share & Trends Analysis Report 2023-2030
August 21, 2023 08:48 ET
|
Research and Markets
Dublin, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The "Hemophilia Market Size, Share & Trends Analysis Report By Type (Hemophilia A), By Treatment Type (On-demand), By Therapy (Gene Therapy &...
Global Hemophilia Market Report 2023: Increased Focus on Prophylactic Treatment Drives Growth
February 22, 2023 04:28 ET
|
Research and Markets
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Hemophilia Market (By Treatment Regimen, Type & Therapy): Insights & Forecast with Potential Impact of COVID-19 (2023-2027)" report has...
Worldwide Hemophilia Treatment Industry to 2030 - by Product, Hemophilia Type and Region
February 02, 2023 12:43 ET
|
Research and Markets
Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Global Blood Plasma Derivatives Market Report 2022: Featuring Bayer, Takeda Pharmaceutical, Grifols, Biotest & More
December 02, 2022 04:53 ET
|
Research and Markets
Dublin, Dec. 02, 2022 (GLOBE NEWSWIRE) -- The "Global Blood Plasma Derivatives Market Size, Share & Industry Trends Analysis Report by Application, End-user, Type (Immunoglobulin, Albumin,...
Global Hemophilia Treatment Market Report to 2031: Players Include Bayer, Pfizer, F. Hoffmann-La Roche and CSL
November 11, 2022 04:50 ET
|
Research and Markets
Dublin, Nov. 11, 2022 (GLOBE NEWSWIRE) -- The "Hemophilia Treatment Market By Type, By Drug Therapy: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ...
Acquired Hemophilia Treatment Global Market Report 2022: Rise in Geriatric Population Remains as Key Growth Driver
August 31, 2022 05:08 ET
|
Research and Markets
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Acquired Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Insights on the Hemophilia Global Market to 2026 - Increased Focus on Prophylactic Treatment Presents Opportunities
March 03, 2022 04:38 ET
|
Research and Markets
Dublin, March 03, 2022 (GLOBE NEWSWIRE) -- The "Global Hemophilia Market: Size, Trends & Forecast with Impact of COVID-19 (2022-2026)" report has been added to ResearchAndMarkets.com's offering....
Global Hemophilia Market Key Trends & Developments 2022-2026: Shifting Focus to Extended Half Life Therapies and Development of Novel Hemophilia Treatments
February 24, 2022 06:48 ET
|
Research and Markets
Dublin, Feb. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Hemophilia Market (By Treatment Regimen, Type & Therapy): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has...